Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Why is Hainan Shuangcheng Pharmaceuticals Co., Ltd. ?

The company has declared positive results for the last 3 consecutive quarters

NET SALES(HY) At CNY 156.3 MM has Grown at 92.49%
OPERATING CASH FLOW(Y) Highest at CNY 86.49 MM
NET PROFIT(HY) Higher at CNY 25.32 MM

With ROE of 5.26%, it has a fair valuation with a 8.60 Price to Book Value

Over the past year, while the stock has generated a return of 11.29%, its profits have risen by 122.9% ; the PEG ratio of the company is 1.3

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Hainan Shuangcheng Pharmaceuticals Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hainan Shuangcheng Pharmaceuticals Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

11.29%

1.87

42.54%

China Shanghai Composite

16.78%

1.20

13.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.72%

EBIT Growth (5y)

19.07%

EBIT to Interest (avg)

-6.17

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.46

Sales to Capital Employed (avg)

0.33

Tax Ratio

0.09%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

164

Industry P/E

Price to Book Value

8.60

EV to EBIT

128.05

EV to EBITDA

52.52

EV to Capital Employed

6.61

EV to Sales

12.97

PEG Ratio

1.33

Dividend Yield

ROCE (Latest)

5.16%

ROE (Latest)

5.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company

NET SALES(HY)

At CNY 156.3 MM has Grown at 92.49%

OPERATING CASH FLOW(Y)

Highest at CNY 86.49 MM

NET PROFIT(HY)

Higher at CNY 25.32 MM

ROCE(HY)

Highest at 8.14%

DEBTORS TURNOVER RATIO(HY)

Highest at 7.76 times

RAW MATERIAL COST(Y)

Fallen by -202.22% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.96 times

-7What is not working for the Company

NET SALES(Q)

At CNY 48.44 MM has Fallen at -29.31%

PRE-TAX PROFIT(Q)

At CNY -0.66 MM has Fallen at -132.47%

NET PROFIT(Q)

At CNY 3.39 MM has Fallen at -28.85%

Here's what is working for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Debtors Turnover Ratio

Highest at 7.76 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Cash Flow

Highest at CNY 86.49 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Highest at 1.96 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -202.22% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Net Sales

At CNY 48.44 MM has Fallen at -29.31%

over average net sales of the previous four periods of CNY 68.52 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -0.66 MM has Fallen at -132.47%

over average net sales of the previous four periods of CNY 2.04 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 3.39 MM has Fallen at -28.85%

over average net sales of the previous four periods of CNY 4.76 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)